Skip to main content
CVE-2025-1244VulnerabilityPublished Updated

Red Hat Security Advisory: emacs security update

Affects Red Hat emacsSource GCVE Database

0
Compare
Authoritative record:CVE-2025-1244· High 8.8

Not known to be exploited · CVSS 8.8 High.

Data as of 3 Nov 2026, 22:57 UTC

CVSS 3.1 base score
8.8High
How severe the flaw is on the 0–10 CVSS scale.

Thin evidence

One scorer or none
CVSS scores by source
CNA (redhat)CVSS 3.18.8
EPSS
2.6% chance of exploitation in 30 days – higher than 85% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 12 Feb 2025

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.

What to do

AI-suggested

Red Hat has released an official security update for GNU Emacs in Red Hat Enterprise Linux 8.6 to fix this shell injection vulnerability. Users should apply the provided update packages as described in the Red Hat advisory (RHSA-2025:1961) and the referenced article https://access.redhat.com/articles/11258. No additional mitigation steps are indicated by the vendor.

Description

A shell injection vulnerability (CVE-2025-1244) exists in GNU Emacs via a custom "man" URI scheme. This vulnerability allows an attacker to inject and execute arbitrary shell commands through specially crafted input. Red Hat has issued a security update for Emacs in Red Hat Enterprise Linux 8.6 to address this issue.

References

Community reviews

Loading reviews…